| Financial Year |
March 31 2023 |
| Monetary Funds |
1,491,768,787.53 |
| Held-for-trading Financial Assets |
252,098,576.77 |
| Notes Receivable |
105,432,926.94 |
| Accounts Receivable |
1,676,440,329.13 |
| Advances to Suppliers |
144,419,233.38 |
| Other Receivables |
230,796,062.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,384,200,461.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
149,518,121.43 |
| Total Current Assets |
6,953,637,345.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
45,960,793.18 |
| Long-term Equity Investment |
403,682,428.06 |
| Investment Properties |
12,570,585.18 |
| Fixed Assetes |
3,318,767,026.40 |
| Under-construction Projects |
492,265,047.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
454,260,911.81 |
| R&D expenses |
-- |
| Goodwill |
360,708,086.68 |
| Long-Term Deferred and Prepaid Expenses |
19,930,842.06 |
| Deferred Income Tax Assets |
334,341,114.82 |
| Other Non-Current Assets |
223,428,264.07 |
| Sub-Total of Non-Current Assets |
6,639,435,851.25 |
| Total Assets |
13,593,073,196.57 |
| Short-Term Loans |
1,651,270,625.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
472,325,742.10 |
| Accounts Payable |
586,398,936.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
56,681,369.17 |
| Taxes Payable |
193,308,023.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
244,236,370.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,381,074.68 |
| Other Current Liabilities |
139,510,852.58 |
| Sub-Total of Current Liabilities |
3,683,130,848.40 |
| Long-term Loans |
312,912,999.54 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
193,130,898.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
659,538,425.81 |
| Total Liabilities |
4,342,669,274.21 |
| Paid-In Capital(Or Share Stock) |
1,173,146,118.00 |
| Capital Surplus |
1,707,864,092.68 |
| Surplus Reserve |
585,071,431.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,196,274,434.70 |
| Minority Stockholder's Interest |
160,438,841.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,089,965,080.70 |
| Owner's Equity（Stockholder's Equity） |
9,250,403,922.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,593,073,196.57 |
